Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedLocations section updated with numerous new sites across the US, Australia, and Europe, and several previously listed sites were removed. This broadens geographic access and may affect enrollment options for potential participants.SummaryDifference3%
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedAdded a note in the Publications section stating that publications are provided voluntarily by the person entering information about the study (rev. 3.3.2). Removed the previous note about voluntary publication of study results (rev. 3.2.0).SummaryDifference0.1%
- Check50 days agoChange DetectedRemoved the government funding notice about potential delays and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check71 days agoChange DetectedNo content additions or deletions were detected between the two screenshots; the page content and structure remain the same, with only minor rendering differences.SummaryDifference0.3%
- Check94 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference2%
- Check101 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content appears to be altered.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.